1-4 of 4
Angelika Mattigk
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Adjuvant Therapy with Pembrolizumab in Renal Cell Carcinoma: Real-World Experiences from a Retrospective, Multi-Institutional Cohort

Available to Purchase
Subject Area:
Further Areas
Angelika Mattigk, Cristina Cano Garcia, Niklas Klümper, Alexander Cox, Oliver Hahn, Kerstin Junker, Kati Erdmann, Philipp Schmucker, Luka Flegar, Friedemann Zengerling, Severine Banek, Jörg Ellinger, Bjoern Thorben Buerk, Johannes Huber, Charis Kalogirou, Philip Zeuschner, Benedikt Hoeh
Journal: Urologia Internationalis
Urol Int (2025) 109 (3): 291–298.
https://doi.org/10.1159/000543278
Published Online: 24 December 2024
View article titled, Adjuvant Therapy with Pembrolizumab in Renal Cell Carcinoma: Real-World Experiences from a Retrospective, Multi-Institutional Cohort
Open the PDF for Adjuvant Therapy with Pembrolizumab in Renal Cell Carcinoma: Real-World Experiences from a Retrospective, Multi-Institutional Cohort in another window
Journal Articles

Discrepancy between German S3 Guideline Recommendations and Daily Urologic Practice in the Management of Nonmuscle Invasive Bladder Cancer: Results of a Binational Survey

Available to Purchase
Subject Area:
Karger e-Journal Backfile Collection 2023 , Further Areas
Julian P. Struck, Martin J.P. Hennig, Marie C. Hupe, Nadim Moharam, Pia Paffenholz, Tim Nestler, Tanja Frank, Thomas S. Worst, Markus Grabbert, Philippe-Fabian Pohlmann, Serkan Dogan, Sebastian L. Hofbauer, Charis Kalogirou, Angelika Mattigk, Maximilian P. Brandt, Laura-Maria Krabbe, Henning Reis, Franz F. Dressler, Mario W. Kramer, Johannes Salem
Journal: Urologia Internationalis
Urol Int (2023) 107 (1): 35–45.
https://doi.org/10.1159/000518166
Published Online: 24 January 2023
View article titled, Discrepancy between German S3 Guideline Recommendations and Daily Urologic Practice in the Management of Nonmuscle Invasive Bladder Cancer: Results of a Binational Survey
Open the PDF for Discrepancy between German S3 Guideline Recommendations and Daily Urologic Practice in the Management of Nonmuscle Invasive Bladder Cancer: Results of a Binational Survey in another window
Journal Articles

Comparison of First-Line Anti-PD-1-Based Combination Therapies in Metastatic Renal-Cell Carcinoma: Real-World Experiences from a Retrospective, Multi-Institutional Cohort

Available to Purchase
Subject Area:
Further Areas
Benedikt Hoeh, Philipp Schmucker, Niklas Klümper, Oliver Hahn, Philip Zeuschner, Severine Banek, Pierre I. Karakiewicz, Jörg Ellinger, Julia Heinzelbecker, Michael Hölzel, Arne Strauß, Friedemann Zengerling, Angelika Mattigk, Charis Kalogirou
Journal: Urologia Internationalis
Urol Int (2022) 106 (11): 1150–1157.
https://doi.org/10.1159/000521661
Published Online: 14 February 2022
View article titled, Comparison of First-Line Anti-PD-1-Based Combination Therapies in Metastatic Renal-Cell Carcinoma: Real-World Experiences from a Retrospective, Multi-Institutional Cohort
Open the PDF for Comparison of First-Line Anti-PD-1-Based Combination Therapies in Metastatic Renal-Cell Carcinoma: Real-World Experiences from a Retrospective, Multi-Institutional Cohort in another window
Journal Articles

Increased Severe Adverse Outcomes and Decreased Emergency Room Visits for Pyelonephritis: First Report of Collateral Damage during COVID-19 Pandemic in Urology

Available to Purchase
Subject Area:
Topic Article Package: Coronavirus (COVID-19) , Further Areas
Hendrik Borgmann, Julian P. Struck, Angelika Mattigk, Mike Wenzel, Adrian Pilatz, Jennifer Kranz, Richard Weiten, Nicolas von Landenberg, Philipp Julian Spachmann, Cem Aksoy, Axel Haferkamp, Katharina Boehm
Journal: Urologia Internationalis
Urol Int (2021) 105 (3-4): 199–205.
https://doi.org/10.1159/000513458
Published Online: 06 January 2021
View article titled, Increased Severe Adverse Outcomes and Decreased Emergency Room Visits for Pyelonephritis: First Report of Collateral Damage during COVID-19 Pandemic in Urology
Open the PDF for Increased Severe Adverse Outcomes and Decreased Emergency Room Visits for Pyelonephritis: First Report of Collateral Damage during COVID-19 Pandemic in Urology in another window